| Issue |
Title |
File |
| Vol 13, No 4 (2011) |
17 noyabrya 2011 g. v ramkakh X Natsional'nogoonkologicheskogo kongressa sostoyalsyasimpozium «Biosimilyary: novye gorizontyrazvitiya zdravookhraneniya» |
|
|
- -.
|
| Vol 14, No 3 (2012) |
22 sentyabrya 2012 g. sostoyalsya press-brifing, posvyashchennyy roli targetnoy terapii v preodolenii lekarstvennoy rezistentnosti pri lechenii metastaticheskogo raka molochnoy zhelezy (mRMZh) i, v chastnosti, predstavleniyu obshchestvennosti novykh zaregistrirovannykh pokazaniy dlya primeneniya preparata Afinitor pri mRMZh |
|
|
- -.
|
| Vol 12, No 4 (2010) |
25 noyabrya 2010 g. «AstraZeneka Rossiya» ob\"yavilapromezhutochnye rezul'taty issledovaniya EPICLIN |
|
|
- -.
|
| Vol 14, No 3 (2012) |
6-9 sentyabrya 2012 g. v Marsele sostoyalsya 10-y kongress Evropeyskoy assotsiatsii po neyroonkologii (EANO) |
|
|
Absalyamova O.V.
|
| Vol 10, No 1 (2008) |
8 let nadezhdy: novye dannye issledovaniya ATAS |
|
|
- -.
|
| Vol 24, No 3 (2022) |
A clinical case of the use of a new selective μ1-opioid analgesic Tafalgin in the treatment of chronic cancer pain |
(Rus)
|
|
Abuzarova G.R., Sarmanayeva R.R., Alekseeva G.S., Brazhnicova Y.V.
|
| Vol 20, No 4 (2018) |
A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer |
(Rus)
|
|
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
|
| Vol 24, No 1 (2022) |
A modern approach to the treatment of cancer-associated venous thromboembolic complications: a lecture |
(Rus)
|
|
Fedorov S.A., Tselousova L.M., Medvedev A.P., Deryabin R.A., Gamayunov S.V.
|
| Vol 17, No 1 (2015) |
A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian |
|
|
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
|
| Vol 23, No 4 (2021) |
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Zhilyakova V.V.
|
| Vol 22, No 4 (2020) |
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Alexandrova E.G.
|
| Vol 24, No 3 (2022) |
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma (Russian Translation of Cochrane Plain Language Summary (PLS)) |
(Rus)
|
|
Suvorov V.A.
|
| Vol 23, No 2 (2021) |
Acalabrutinib in the treatment of chronic lymphocytic leukemia: a review of recent evidence |
(Rus)
|
|
Petrenko A.A., Kislova M.I., Dmitrieva E.A., Nikitin E.A.
|
| Vol 22, No 2 (2020) |
Accompanying therapy in oncohematological patients with secondary immunodeficiency |
(Rus)
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 23, No 4 (2021) |
Activation of the PI3K-AKT-mTOR cascade in uterine leiomyosarcoma: a retrospective study of 31 patients |
(Rus)
|
|
Rozonova O.A., Artamonova E.V., Kozlov N.A., Delektorskaya V.V., Egorova A.V., Stilidi I.S.
|
| Vol 23, No 1 (2021) |
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma |
(Rus)
|
|
Ignatova A.V.
|
| Vol 17, No 3 (2015) |
Adenosquamous carcinoma of the colon: case report |
|
|
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
|
| Vol 22, No 2 (2020) |
Adjuvant targeted therapy for non-small cell lung cancer |
(Rus)
|
|
Laktionov K.K., Kazakov A.M., Gordiev M.G., Kononets P.V., Akhmedov B.B., Maevskaia J.N.
|
| Vol 9, No 2 (2007) |
Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy |
|
|
Semiglazov V.F., Semiglazov V.V.
|
| Vol 3, No 2 (2001) |
Ad\"yuvantnaya khimioterapiya raka molochnoy zhelezy: ot alkiliruyushchikh preparatov i antimetabolitov k antratsiklinam i taksonam |
|
|
Voznyy E.K.
|
| Vol 11, No 4 (2009) |
Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey |
|
|
Nikulin M.P., Stilidi I.S.
|
| Vol 10, No 1 (2008) |
Ad\"yuvantnoe lechenie raka tolstoy kishki |
|
|
Artamonova E.V., Podregul'skiy K.E.
|
| Vol 17, No 3 (2015) |
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial |
|
|
Soria J., Felip E., Cobo M., Lu S., Syrigos K., Lee K.H., Göker E., Georgoulias V., Li W., Isla D., Guclu S.Z., Morabito A., Min Y.J., Ardizzoni A., Gadgeel S.M., Wang B., Chand V.K., Goss G.D.
|
| Vol 3, No 4 (2001) |
Aktivatory plazminogena urokinaznogo i tkanevogo tipov i ikh ingibitor pervogo tipa pri rake pishchevoda (predvaritel'nye rezul'taty) |
|
|
Gershteyn E.S., Goncharov D.Y., Kushlinekiy N.E., Poddubnaya I.V.
|
| Vol 12, No 4 (2010) |
Aktivnaya khirurgicheskaya taktikav sovremennom algoritme lecheniyarasprostranennogo raka yaichnika |
|
|
Pokataev I.A., Stenina M.B., Tyulyandina A.S., Tyulyandin S.A.
|
| Vol 2, No 1 (2000) |
Aktual'nye voprosy limfodissektsii u bol'nykh rakom grudnogo otdela pishchevoda |
|
|
Davydov M.I., Stilidi I.S., Arzykulov D.A., Ter-Ovanesov M.D., Godzhamanov Y.G., Lagoshnyy A.T.
|
| Vol 19, No 1 (2017) |
Albumin-bound paclitaxel in the treatment of metastatic breast cancer |
(Rus)
|
|
Artamonova E.V.
|
| Vol 16, No 2 (2014) |
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives |
|
|
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
|
| Vol 12, No 1 (2010) |
Alimta (pemetreksed) v pervoylinii lecheniya disseminirovannogonemelkokletochnogo raka legkogo |
|
|
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
|
| Vol 13, No 3 (2011) |
Allel'nye varianty v genakh BRCA1,BRCA2, TP53, assotsiirovannyes razvitiem raka molochnoy zhelezy |
|
|
Sytenkova K.V., Guzieva Z.M., Kazakov M.P., Lyubchenko L.N., Poddubnaya I.V.
|
| Vol 23, No 4 (2021) |
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Gainudinova D.R.
|
| Vol 9, No 2 (2007) |
Ambulatornoe lechenie khronicheskogo limfoleykoza: doma i steny pomogayut v ramkakh mezhdunarodnogo meditsinskogo simpoziuma «Rekomenduy svobodu!» |
|
|
- -.
|
| Vol 12, No 4 (2010) |
Analiz bazovykh issledovaniy III fazy podtverzhdaetpreimushchestvo denosumaba pered standartnoy terapieyu bol'nykh s metastaticheskim porazheniem kostey |
|
|
- -.
|
| Vol 6, No 4 (2004) |
Analiz lecheniya onkoginekologicheskikh opukholey v Yakutii |
|
|
Kipriyanova N.S., Afanas'eva L.N., Aksel' E.M., Poddubnaya I.V.
|
| Vol 7, No 1 (2005) |
Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere |
|
|
Chevardov N.I., Tolstykh L.V., Puzakov K.G., Potapov Y.N.
|
| Vol 5, No 3 (2003) |
Analiz sostoyaniya onkoginekologicheskoy pomoshchi naseleniyu v Respublike Sakha (Yakutiya) |
|
|
Aksel' E.M., Afanas'eva L.N., Kipriyanova N.S., Smetanina V.D., Poddubnaya I.V.
|
| Vol 8, No 3 (2006) |
Analiz sostoyaniya onkoginekologicheskoy pomoshchi v navoiyskom regione (Respublika Uzbekistan) |
|
|
Kudryavtsev I.Y., Kerimov R.A.
|
| Vol 5, No 3 (2003) |
Analiz sostoyaniya onkologicheskoy pomoshchi v Respublike Sakha (Yakutiya) za 1991-2001 gg |
|
|
Poddubnaya I.V., Aksel' E.M., Kipriyanova N.S.
|
| Vol 13, No 3 (2011) |
Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii |
|
|
Ryazhenov V.V., Gorokhova S.G.
|
| Vol 24, No 3 (2022) |
Analysis of the complications of endocrine therapy with tamoxifen in breast cancer: clinical and pharmacogenetic aspects. Prospective pharmacogenetic cohort study |
(Rus)
|
|
Savelyeva M.I., Golubenko E.O., Sozaeva Z.A., Poddubnaya I.V., Korennaya V.V.
|
| Vol 23, No 1 (2021) |
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice |
(Rus)
(Eng)
|
|
Kolyadina I.V., Abidova N.R., Akopyan A.A., Antonova G.V., Arapova O.I., Bobrova E.A., Bolotina L.V., Valiakhmetova C.K., Vasilevskaya A.V., Vladimirova L.Y., Volkonskiy M.V., Ganshina I.P., Gudkova I.E., Dergunov A.S., Evstigneeva I.V., Egurenkova V.S., Emshanov A.V., Zhukova L.G., Zueva E.V., Karabina E.V., Kolokolov J.J., Kuzmicheva S.V., Kuchevskaya O.A., Luev I.A., Maistrenko K.S., Markizova E.V., Marfutov V.V., Medvedev S.P., Merzlikina Y.I., Nersesova T.A., Ovchinnikova E.G., Orlova S.A., Samaneva N.Y., Stativko O.A., Storozhakova A.E., Stroyakovskiy D.L., Sultanbaev A.V., Tekeeva A.I., Fadeeva N.V., Fedorova A.N., Shalaeva O.M., Shangina I.A., Shirokova O.N., Shumskikh A.R., Yakubova M.Z.
|
| Vol 10, No 2 (2008) |
ANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYu |
|
|
Semenova A.A., Sorokin E.N., Poddubnaya I.V., Probatova N.A., Timofeeva O.L.
|
| Vol 4, No 1 (2002) |
Anastrozol kak perspektiva ad\"yuvantnogo lecheniya raka molochnoy zhelezy u bol'nykh v menopauze |
|
|
Gorbunova V.A.
|
| Vol 24, No 4 (2022) |
Anemia and iron deficiency in cancer patients: the role of intravenous iron supplements (a literature review) |
(Rus)
|
|
Sakaeva D.D.
|
| Vol 12, No 3 (2010) |
Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh |
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 4, No 3 (2002) |
Anemiya pri zlokachestvennykh opukholyakh |
|
|
Breder V.V., Gorbunova V.A., Besova N.S.
|
| Vol 13, No 2 (2011) |
Anemiya pri zlokachestvennykhnovoobrazovaniyakh: printsipy terapii |
|
|
Gorokhovskaya G.N., Petina M.M.
|
| Vol 14, No 1 (2012) |
Anemiya v onkologii:podkhody k lecheniyu |
|
|
Ptushkin V.V.
|
| Vol 16, No 2 (2014) |
Angiogenesis as a target for cancer therapy |
|
|
Imyanitov E.N.
|
| Vol 23, No 2 (2021) |
Anti-anemia drugs shorten survival for some cancer patients (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Ziganshin A.U.
|
| Vol 23, No 1 (2021) |
Antiangiogenic therapy for breast cancer with triple negative phenotype |
(Rus)
|
|
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
|
| Vol 23, No 3 (2021) |
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features |
(Rus)
|
|
Reutova E.V., Laktionov K.K.
|
| Vol 15, No 3 (2013) |
Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka |
|
|
Meshcheryakov A.A.
|
| Vol 14, No 2 (2012) |
Antiangiogennaya terapiya v lechenii glioblastomy: obzor i sobstvennye klinicheskie dannye |
|
|
Kobyakov G.L., Absalyamova O.V., Urakov S.V., Smolin A.V., Strazhev S.V.
|
| Vol 13, No 4 (2011) |
Antiangiogennaya terapiyapri rake molochnoy zhelezys troynym negativnym fenotipom |
|
|
Zhukova L.G.
|
| Vol 2, No 1 (2000) |
Antiemetogennaya terapiya ondasetronom pri polikhimioterapii zlokachestvennykh opukholey u devochek |
|
|
Safonova S.A., Punanov Y.A., Kolygin B.A.
|
| Vol 9, No 1 (2007) |
Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy? |
|
|
Ptushkin V.V.
|
| Vol 24, No 3 (2022) |
Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report |
(Rus)
|
|
Grechukhina K.S., Vorontsova K.A., Filonenko D.A., Tyutyunnik P.S., Shchadrova V.V., Zhukova L.G.
|
| Vol 19, No 1 (2017) |
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers |
(Rus)
|
|
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
|
| Vol 24, No 2 (2022) |
Are oral blood thinners safe and effective for people being treated for cancer? |
(Rus)
|
|
Ziganshin A.U.
|
| Vol 2, No 1 (2000) |
Arimideks - novyy nesteroidnyy selektivnyy ingibitor aromatazy Predvaritel'nye rezul'taty "Otkrytogo nesravnitel'nogo issledovaniya po otsenke effektivnosti i perenosimosti arimideksa ( 1 mg) pri lechenii rasprostranennogo raka molochnoy zhelezy u zhenshchin |
|
|
Gorbunova V.A., Gorin A.M., Odintsov S.V., Kozlov D.V., Vychkov M.V., Dobrovol'skaya N.Y., Vazin I.G., Meshcheryakov A.A.
|
| Vol 5, No 4 (2003) |
Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy |
|
|
Semiglazov V.F., Zhil'tsova E.K., Semiglazov V.V., Ivanov V.G., Dashyan G.A., Klettsel' A.A., Bozhok A.A., Nurgaziev K.S., Topuzov E.E., Krivorot'ko P.V., Tsyrlina E.V., Bershteyn L.M.
|
| Vol 3, No 4 (2001) |
Arimideks: novye vozmozhnosti v lechenii generalizovannogo raka molochnoy zhelezy |
|
|
Borisov V.I.
|
| Vol 7, No 2 (2005) |
Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy |
|
|
Makarenko N.P.
|
| Vol 11, No 4 (2009) |
Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy |
|
|
Artamonova E.V.
|
| Vol 7, No 3 (2005) |
Aromazin: printsip deystviya |
|
|
Imyanitov E.N.
|
| Vol 13, No 3 (2011) |
ASCO 2011: novye standartyv lechenii stromal'nykh opukholeyzheludochno-kishechnogo trakta |
|
|
Nikulin M.P.
|
| Vol 10, No 2 (2008) |
ASCO Innovatsionnye metody bor'by s onkologicheskimi zabolevaniyam |
|
|
- -.
|
| Vol 23, No 1 (2021) |
Assessment and correction of the geriatric status of patients with metastatic colorectal cancer during the first-line systemic therapy |
(Rus)
|
|
Alekseeva Y.V., Semiglazova T.Y., Sharashenidze S.M., Tkachenko E.V., Kasparov B.S., Brish N.A., Teletaeva G.M., Filatova L.V., Sluzhev M.I., Semiglazov V.V., Protsenko S.A., Belyaev A.M.
|
| Vol 24, No 1 (2022) |
Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms" |
(Rus)
|
|
Ryazhenov V.V., Orlov S.V., Ivakhnenko O.I.
|
| Vol 12, No 3 (2010) |
Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury) |
|
|
Shafigullin M.R., Ivanov S.V., Gorbunova V.A., Meshcheryakov A.A.
|
| Vol 7, No 2 (2005) |
Astrotsitomy nizkoy stepeni zlokachestvennosti polushariy bol'shogo mozga |
|
|
Aleshin V.A., Karakhan V.B.
|
| Vol 24, No 1 (2022) |
Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 17, No 3 (2015) |
Atsellbiya® - opyt primeneniya pervogo bioanaloga rituksimaba v rutinnoy praktike klinitsista |
|
|
- -.
|
| Vol 18, No 5 (2016) |
Autologous stem cells transplantation in the first remission of follicular lymphoma as "rescue therapy" in patients with unfavorable prognosis factors. The first prospective study results |
|
|
Nesterova E.S., Kravchenko S.K., Baryakh E.A., Misyurina A.E., Mangasarova Y.K., Vorobev V.I., Chernova N.G., Gemdzhian E.G., Savchenko V.G.
|
| Vol 22, No 4 (2020) |
Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case |
(Rus)
|
|
Filonenko D.A., Medvedeva B.M., Meshcheryakov A.A.
|
| Vol 16, No 3 (2014) |
Avastin in clinical chemotherapy of malignant tumors |
|
|
Gorbunova V.A.
|
| Vol 19, No 3 (2017) |
BCD-100 - first russian PD-1 inhibitor |
(Rus)
|
|
Tyulyandin S.A., Fedyanin M.Y., Semiglazova T.Y., Moiseenko V.M., Odintsova S.V., Alekseev B.Y., Ivanov R.A., Shustova M.S.
|
| Vol 14, No 2 (2012) |
Bendamustin v terapii nekhodzhkinskikh limfom |
|
|
Semenova A.A.
|
| Vol 20, No 4 (2018) |
Bendamustine in the treatment of B-cell non-Hodgkin lymphoma |
(Rus)
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 24, No 2 (2022) |
Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative breast cancer |
(Rus)
|
|
Evdokimova Y.L.
|
| Vol 16, No 3 (2014) |
Bevacizumab in advanced ovarian cancer: when, what for and why? |
|
|
Tjulandina A.S.
|
| Vol 11, No 1 (2009) |
Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO) |
|
|
Zhukova L.G.
|
| Vol 12, No 1 (2010) |
Bevatsizumab pri metastaticheskomi retsidiviruyushchem rake molochnoy zhelezy:metaanaliz randomizirovannykh issledovaniy |
|
|
Kolyadina I.V., Poddubnaya I.V.
|
| Vol 15, No 3 (2013) |
Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy |
|
|
Smolin A.V., Konev A.V., Kobyakov G.L., Nikolaeva S.N., Shamanskaya Y.E., Gorbunov A.V.
|
| Vol 15, No 3 (2013) |
Bevatsizumab v kombinatsii s khimioterapiey pri rake molochnoy zhelezy |
|
|
Manzyuk L.V., Kovalenko E.I., Artamonova E.V., Osmanova L.I.
|
| Vol 12, No 3 (2010) |
Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti |
|
|
Zhukova L.G.
|
| Vol 12, No 3 (2010) |
Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii |
|
|
Semenov N.N.
|
| Vol 22, No 2 (2020) |
Biobanks in oncology: global experience and Russian reality |
(Rus)
|
|
Kaprin A.D., Ivanov S.A., Petrov V.A., Dukhova N.N., Dvinskikh N.I., Falaleeva N.A., Grivtsova L.I.
|
| Vol 18, No 2 (2016) |
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study |
(Rus)
|
|
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
|
| Vol 23, No 2 (2021) |
Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization |
(Rus)
|
|
Kolyadina I.V., Butrimova A.S., Poddubnaya I.V., Kоmetova V.V., Rodionov V.V.
|
| Vol 7, No 2 (2005) |
Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy |
|
|
Nikolaeva T.G., Vyshinskaya G.V., Rotobel'skaya L.E.
|
| Vol 13, No 4 (2011) |
Biosimilyary: novye vozmozhnostisovremennoy lekarstvennoy terapiiopukholey |
|
|
Poddubnaya I.V.
|
| Vol 24, No 2 (2022) |
Blood thinners for the initial treatment of blood clots in people with cancer |
(Rus)
|
|
Ziganshin A.U.
|
| Vol 10, No 3 (2008) |
Bondronat v forme dlya priema vnutr' effektiven u bol'nykh s kostnymi metastazami raka molochnoy zhelezy. Opyt odnogo tsentra |
|
|
Semenov N.N., Lichinitser M.R., Vyshinskaya G.V., Meshcheryakov A.A., Novikov V.V., Gutorov S.L., Borisova E.I., Nakhalova T.A., Mikhina Z.P., Lyubimova N.V., Chaklina E.A., Aplevich N.N.
|
| Vol 15, No 4 (2013) |
Bone mineral density in patient with breast cancer |
|
|
Poddubnaya I.V., Kizhaev E.V., Kolyadina I.V., Banov S.M., Zhmaeva E.M., Secko M.A.
|
| Vol 19, No 2 (2017) |
Brachytherapy with ultrasound assistance in patients with cervical cancer |
(Rus)
|
|
Kizhaev Y.E., Razumova E.L., Bessolova O.V.
|
| Vol 17, No 2 (2015) |
Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy |
|
|
Artamonova E.V., Manziuk L.V.
|
| Vol 18, No 1 (2016) |
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) |
(Rus)
|
|
Khokhlova S.V., Gorbunova V.A., Lyubchenko L.N., Imyanitov E.N.
|
| Vol 23, No 1 (2021) |
Breast cancer |
(Rus)
|
|
Zhukova L.G., Andreeva I.I., Zavalishina L.E., Zakiriakhodzhaev A.D., Koroleva I.A., Nazarenko A.V., Paltuev R.M., Parokonnaia A.A., Petrovskii A.V., Portnoi S.M., Semiglazov V.F., Semiglazova T.I., Stenina M.B., Stepanova A.M., Trofimova O.P., Tyulyandin S.A., Frank G.A., Frolova M.A., Shatova I.S., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| 1 - 100 of 1215 Items |
1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
